Eli Lilly and Co. stock trades at EUR 1031.20, market cap USD 1,088.7 billion

Published on 10/08/2026 at 20:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eli Lilly and Co. stock costs EUR 1031.20 on October 8, 2026, minus 2.73 percent. Next earnings are scheduled for October 29, 2026.

Key points in brief

Eli Lilly and Co. stock was EUR 1031.20 in after-hours trading on October 8, 2026, minus 2.73 percent versus the EUR 1060.10 prior close.
The primary-exchange quote was USD 1156.00, while the 52-week range was USD 783.85 to USD 1292.65.
Market capitalization stood at USD 1,088.7 billion and the trailing P/E ratio was 38.8.
Eli Lilly and Company lists its next earnings report for October 29, 2026.

Draufsicht-Flatlay auf weißem Untergrund: Siliziumwafer, FOUP-Wafer-Carrier, Pinzetten, Reinraumhandschuhe und Messinstrumente — Lam Research US5324571083 Flatlay mit Silizium Wafern Wafer Carrier und Praezisionswerkzeug auf weissem Untergrund, Illustration mit AI erstellt.

Eli Lilly and Co. (ISIN US5324571083) was trading at EUR 1031.20 at Lang & Schwarz on October 8, 2026 at 8:35 p.m. CEST in after-hours trading, minus 2.73 percent versus the EUR 1060.10 prior close. The euro quotation places the session move below the previous evening's level for German-market investors.

Intraday levels and volume

The primary-exchange quote was USD 1156.00 at 2:39 p.m. ET on October 8, 2026, minus 2.75 percent from USD 1188.72. Trading volume was 1,926,085 shares, compared with an average volume of 2,473,082 shares.

The USD 136.72 gap between the 52-week high and the latest primary-exchange quote leaves the stock 10.57 percent below its USD 1292.65 high. The 52-week low was USD 783.85, so the quoted USD 1156.00 level stood 47.48 percent above that low.

Valuation remains measurable

Eli Lilly and Company's market capitalization was USD 1,088.7 billion on October 8, 2026. The trailing P/E ratio was 38.8, while the dividend yield was 0.01 percent.

The valuation figures give the price move a clear numerical frame without assigning a cause to it. The primary-exchange price remained below the 52-week high, while the market value stayed above USD 1 trillion.

Comparison with peers

Eli Lilly and Co.: minus 2.73 percent, P/E 38.8, market capitalization USD 1,088.7 billion
Novo Nordisk (NYSE, USD): minus 1.05 percent, P/E 9.5, market capitalization USD 168.1 billion
Merck & Co. (NYSE, USD): minus 0.88 percent, P/E 113.2, market capitalization USD 349.6 billion

Next report date

Eli Lilly and Company lists its next earnings call for October 29, 2026 at 10:00 a.m. EDT. That date gives the market a fixed calendar point after the October 8 quotation.

Price and market context

The stock's October 8 position combines a EUR 1031.20 Lang & Schwarz after-hours quote with a USD 1156.00 primary-exchange quotation, a USD 1,088.7 billion market capitalization and a 38.8 trailing P/E ratio. The two currency perspectives are kept separate because they refer to different venues.

The further course of trading is shown by the continuously updated real-time quote of Eli Lilly and Co. stock.